| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.15e-07 | 118 | 158 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD2 TBC1D3H MYO9A MYO9B ARFGEF1 TBC1D8B TBC1D3B RGS7 TBC1D3G USP6NL | 7.85e-05 | 279 | 158 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G HSP90B1 MYH11 MYO9A MYO9B KIF16B YTHDC2 AK9 MSH6 DNAH12 ACSBG1 CHD5 DNAH5 DYNC1H1 TDRD12 | 1.12e-04 | 614 | 158 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | Krueppel-associated box domain binding | 1.86e-04 | 3 | 158 | 2 | GO:0035851 | |
| GeneOntologyMolecularFunction | Pyrin domain binding | 1.86e-04 | 3 | 158 | 2 | GO:0032090 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD2 TBC1D3H KALRN MYO9A MYO9B ARFGEF1 TBC1D8B TBC1D3B RGS7 SBF2 TBC1D3G USP6NL PLCE1 | 2.03e-04 | 507 | 158 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD2 TBC1D3H KALRN MYO9A MYO9B ARFGEF1 TBC1D8B TBC1D3B RGS7 SBF2 TBC1D3G USP6NL PLCE1 | 2.03e-04 | 507 | 158 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.26e-04 | 38 | 158 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | histone binding | 2.68e-04 | 265 | 158 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.63e-04 | 18 | 158 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type I (single strand cut, ATP-independent) activity | 3.69e-04 | 4 | 158 | 2 | GO:0003917 | |
| GeneOntologyMolecularFunction | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 6.13e-04 | 5 | 158 | 2 | GO:0004579 | |
| GeneOntologyMolecularFunction | oligosaccharyl transferase activity | 6.13e-04 | 5 | 158 | 2 | GO:0004576 | |
| GeneOntologyMolecularFunction | protein decrotonylase activity | 6.13e-04 | 5 | 158 | 2 | GO:0160008 | |
| GeneOntologyMolecularFunction | histone decrotonylase activity | 6.13e-04 | 5 | 158 | 2 | GO:0160009 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.37e-03 | 103 | 158 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.38e-03 | 28 | 158 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | SEMA4D TBC1D3H KALRN MYO9A MYO9B ARFGEF1 TBC1D8B TBC1D3B RGS7 PTK2 TBC1D3G USP6NL EPHA3 | 2.23e-06 | 335 | 160 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | organelle assembly | CDC14C MYH11 NRAP SPTBN2 HAUS3 BBS5 FNBP1L TUBGCP2 TUBGCP5 RFX2 CDC14B PIKFYVE FSIP2 DNAI1 LRGUK RAB33A MARK4 ASPM UHRF1 ATM DNAH5 CFAP69 USP6NL DYNC1H1 HDAC2 | 2.35e-06 | 1138 | 160 | 25 | GO:0070925 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CDC14C NUP85 BBS5 FNBP1L BIN3 RFX2 CDC14B FSIP2 DNAI1 LRGUK MARK4 PRKCD DAAM2 DNAH5 CFAP69 USP6NL PLCE1 | 1.87e-05 | 670 | 160 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | SEMA4D TBC1D3H KALRN MYO9A MYO9B TBC1D8B TBC1D3B RGS7 TBC1D3G USP6NL | 2.15e-05 | 244 | 160 | 10 | GO:0043547 |
| GeneOntologyBiologicalProcess | cell projection assembly | CDC14C NUP85 BBS5 FNBP1L BIN3 RFX2 CDC14B FSIP2 DNAI1 LRGUK MARK4 PRKCD DAAM2 DNAH5 CFAP69 USP6NL PLCE1 | 2.47e-05 | 685 | 160 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | RGPD2 SEMA4D TBC1D3H KALRN MYO9A MYO9B BCL2 DBI TBC1D8B CDC14B TBC1D3B RGS7 PTK2 MAP3K4 MSH6 MASTL UHRF1 PRKCD ADAM17 TBC1D3G USP6NL | 4.77e-05 | 1028 | 160 | 21 | GO:0043085 |
| GeneOntologyBiologicalProcess | DNA topological change | 5.28e-05 | 10 | 160 | 3 | GO:0006265 | |
| GeneOntologyBiologicalProcess | macrophage chemotaxis | 7.32e-05 | 56 | 160 | 5 | GO:0048246 | |
| GeneOntologyBiologicalProcess | cilium organization | CDC14C BBS5 FNBP1L RFX2 CDC14B FSIP2 DNAI1 LRGUK TTC29 MARK4 DNAH5 CFAP69 USP6NL | 9.03e-05 | 476 | 160 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RGPD2 SEMA4D TBC1D3H KALRN MYO9A MYO9B BCL2 DBI NIBAN2 TBC1D8B CDC14B TBC1D3B RGS7 PTK2 MAP3K4 MSH6 KDM4D MASTL UHRF1 PRKCD ADAM17 TBC1D3G USP6NL HDAC1 HDAC2 | 1.09e-04 | 1430 | 160 | 25 | GO:0044093 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDC14C HAUS3 TUBGCP2 TUBGCP5 CDC14B PTK2 FSIP2 DNAI1 LRGUK MARK4 ASPM UHRF1 DNAH5 CFAP69 DYNC1H1 EPHA3 | 1.57e-04 | 720 | 160 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | cilium assembly | CDC14C BBS5 FNBP1L RFX2 CDC14B FSIP2 DNAI1 LRGUK MARK4 DNAH5 CFAP69 USP6NL | 1.86e-04 | 444 | 160 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | sexual reproduction | FKBP6 NOX5 YTHDC2 BCL2 TUBGCP2 H1-9P TUBGCP5 RFX2 PKDREJ HVCN1 FSIP2 MSH6 LRGUK AFP CHD5 XRN1 ASPM MASTL PRSS42P GJA10 ATM CFAP69 TDRD12 | 2.04e-04 | 1312 | 160 | 23 | GO:0019953 |
| GeneOntologyCellularComponent | DNA topoisomerase III-beta-TDRD3 complex | 5.82e-05 | 2 | 160 | 2 | GO:0140225 | |
| GeneOntologyCellularComponent | NuRD complex | 2.77e-04 | 17 | 160 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 2.77e-04 | 17 | 160 | 3 | GO:0090545 | |
| GeneOntologyCellularComponent | protein-lipid complex | 4.56e-04 | 47 | 160 | 4 | GO:0032994 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.08e-04 | 238 | 160 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | gamma-tubulin complex | 5.29e-04 | 21 | 160 | 3 | GO:0000930 | |
| GeneOntologyCellularComponent | equatorial microtubule organizing center | 5.73e-04 | 5 | 160 | 2 | GO:0000923 | |
| GeneOntologyCellularComponent | dynein complex | 7.76e-04 | 54 | 160 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD2 HSP90B1 KALRN MYO9B SPTBN2 ARFGEF1 YTHDC2 BCL2 DBI PTK2 MAP3K4 PIKFYVE GRK3 SBF2 BYSL PRKCD HDAC1 | 8.34e-04 | 934 | 160 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | microtubule | KIF16B HAUS3 TUBGCP2 TUBGCP5 DNAI1 SAA1 SAA2 DNAH12 ASPM BYSL DNAH5 DYNC1H1 | 8.46e-04 | 533 | 160 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | axonemal dynein complex | 8.94e-04 | 25 | 160 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | spindle | CDC14C NUP85 KIF16B HAUS3 TUBGCP2 TUBGCP5 CDC14B ASPM UHRF1 MICAL3 ATM | 1.04e-03 | 471 | 160 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | heterochromatin | 1.08e-03 | 101 | 160 | 5 | GO:0000792 | |
| GeneOntologyCellularComponent | myosin complex | 1.08e-03 | 59 | 160 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.52e-03 | 161 | 160 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1S MYH11 NRAP MYO9A MYO9B KIF16B HAUS3 DBI TUBGCP2 TUBGCP5 DNAI1 SAA1 SAA2 DNAH12 GRK3 ASPM BYSL DNAH5 DYNC1H1 | 1.73e-03 | 1179 | 160 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1S MYH11 NRAP MYO9A MYO9B KIF16B HAUS3 DBI TUBGCP2 TUBGCP5 DNAI1 SAA1 SAA2 DNAH12 GRK3 ASPM BYSL DNAH5 DYNC1H1 | 1.87e-03 | 1187 | 160 | 19 | GO:0099081 |
| Domain | P-loop_NTPase | MYO1G MYH11 NLRP7 MYO9A MYO9B KIF16B YTHDC2 AK9 NLRP2 SEPTIN8 MSH6 LRGUK RAB33A DNAH12 MPP4 CHD5 ASPM DNAH5 DYNC1H1 TDRD12 | 2.71e-05 | 848 | 156 | 20 | IPR027417 |
| Domain | TBC | 5.40e-05 | 49 | 156 | 5 | SM00164 | |
| Domain | Synaptotagmin1 | 6.93e-05 | 2 | 156 | 2 | IPR015428 | |
| Domain | RabGAP-TBC | 7.92e-05 | 53 | 156 | 5 | PF00566 | |
| Domain | Rab-GTPase-TBC_dom | 9.47e-05 | 55 | 156 | 5 | IPR000195 | |
| Domain | TBC_RABGAP | 9.47e-05 | 55 | 156 | 5 | PS50086 | |
| Domain | RA | 1.24e-04 | 31 | 156 | 4 | SM00314 | |
| Domain | C2 | 1.54e-04 | 137 | 156 | 7 | SM00239 | |
| Domain | C2 | 1.92e-04 | 142 | 156 | 7 | PS50004 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.94e-04 | 14 | 156 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.94e-04 | 14 | 156 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.94e-04 | 14 | 156 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.94e-04 | 14 | 156 | 3 | IPR011704 | |
| Domain | AAA_8 | 1.94e-04 | 14 | 156 | 3 | PF12780 | |
| Domain | AAA_5 | 1.94e-04 | 14 | 156 | 3 | PF07728 | |
| Domain | RA | 2.24e-04 | 36 | 156 | 4 | PF00788 | |
| Domain | DHC_fam | 2.42e-04 | 15 | 156 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.42e-04 | 15 | 156 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.42e-04 | 15 | 156 | 3 | IPR004273 | |
| Domain | - | 2.48e-04 | 148 | 156 | 7 | 2.60.40.150 | |
| Domain | RA | 2.50e-04 | 37 | 156 | 4 | PS50200 | |
| Domain | Myosin_head_motor_dom | 2.77e-04 | 38 | 156 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.77e-04 | 38 | 156 | 4 | PS51456 | |
| Domain | Myosin_head | 2.77e-04 | 38 | 156 | 4 | PF00063 | |
| Domain | MYSc | 2.77e-04 | 38 | 156 | 4 | SM00242 | |
| Domain | IQ | 3.18e-04 | 71 | 156 | 5 | PF00612 | |
| Domain | RA_dom | 3.39e-04 | 40 | 156 | 4 | IPR000159 | |
| Domain | SAA | 4.11e-04 | 4 | 156 | 2 | PS00992 | |
| Domain | His_deacetylse_1 | 4.11e-04 | 4 | 156 | 2 | IPR003084 | |
| Domain | SAA | 4.11e-04 | 4 | 156 | 2 | SM00197 | |
| Domain | SAA | 4.11e-04 | 4 | 156 | 2 | PF00277 | |
| Domain | C2_dom | 4.61e-04 | 164 | 156 | 7 | IPR000008 | |
| Domain | IQ | 5.86e-04 | 81 | 156 | 5 | SM00015 | |
| Domain | Spc97_Spc98 | 6.82e-04 | 5 | 156 | 2 | PF04130 | |
| Domain | GCP | 6.82e-04 | 5 | 156 | 2 | IPR007259 | |
| Domain | Serum_amyloid_A | 6.82e-04 | 5 | 156 | 2 | IPR000096 | |
| Domain | C2 | 8.17e-04 | 131 | 156 | 6 | PF00168 | |
| Domain | Ubiquitin-rel_dom | 9.12e-04 | 184 | 156 | 7 | IPR029071 | |
| Domain | PH_dom-like | RGPD2 KALRN SPTBN2 NIBAN2 BBS5 PTK2 GTF2H1 GRK3 PLCH2 SBF2 PLCE1 | 9.23e-04 | 426 | 156 | 11 | IPR011993 |
| Domain | IQ_motif_EF-hand-BS | 9.47e-04 | 90 | 156 | 5 | IPR000048 | |
| Domain | IQ | 1.10e-03 | 93 | 156 | 5 | PS50096 | |
| Domain | Metallophos | 1.61e-03 | 28 | 156 | 3 | PF00149 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.61e-03 | 28 | 156 | 3 | IPR004843 | |
| Domain | - | 1.69e-03 | 391 | 156 | 10 | 2.30.29.30 | |
| Domain | DHC_N1 | 1.88e-03 | 8 | 156 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.88e-03 | 8 | 156 | 2 | IPR013594 | |
| Domain | Metallo-depent_PP-like | 1.97e-03 | 30 | 156 | 3 | IPR029052 | |
| Domain | - | 1.97e-03 | 30 | 156 | 3 | 3.60.21.10 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 6.56e-06 | 5 | 124 | 3 | MM15874 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F NUP85 KALRN MYO9B CDK12 PIEZO1 POMGNT1 CDC14B TINAGL1 PIKFYVE ESRP2 TDRD3 CLCN7 TULP4 CHD5 SBF2 RRP12 MARK4 AP1G2 MICAL3 TOP3B DYNC1H1 | 8.52e-09 | 1105 | 160 | 22 | 35748872 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90B1 POLR1A ERP44 RPN1 MATR3 PPIL4 HAT1 YTHDC2 STT3B MSH6 FAF2 UTP4 RRP12 BYSL UHRF1 PRKCD AFDN ATM DNAH5 CLUH PHIP DYNC1H1 TMEM117 HDAC1 | 4.10e-08 | 1425 | 160 | 24 | 30948266 |
| Pubmed | ZNF131 HSP90B1 RPN1 DNAJC16 WWP2 PIEZO1 SPTBN2 KIF16B NIBAN2 CMAS CEMIP2 STT3B FAF2 CLCN7 UTP4 RRP12 MRPS21 ASPM BYSL ALAS1 ATM TOP3B CLUH USP6NL | 9.03e-08 | 1487 | 160 | 24 | 33957083 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 31782885 | ||
| Pubmed | Histone deacetylase regulation of ATM-mediated DNA damage signaling. | 9.56e-08 | 3 | 160 | 3 | 23939379 | |
| Pubmed | Immunoexpression of HDAC1, HDAC2, and HAT1 in actinic cheilitis and lip squamous cell carcinoma. | 9.56e-08 | 3 | 160 | 3 | 28107582 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEMA3F HSP90B1 MAN2A1 ERP44 RPN1 DNAJC16 PIEZO1 ARFGEF1 POMGNT1 H6PD CEMIP2 STT3B DMAP1 NEK4 CYB5B PRCP RRP12 EDEM2 UHRF1 ADAM17 ATM | 1.70e-07 | 1201 | 160 | 21 | 35696571 |
| Pubmed | Inhibition of N-glycan processing modulates the network of EDEM3 interactors. | 2.58e-07 | 57 | 160 | 6 | 28366632 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSP90B1 POLR1A RPN1 MYO9A MYO9B MATR3 PPIL4 CMAS PTK2 MSH6 GTF2H1 FAF2 UTP4 RRP12 XRN1 ASPM BYSL AP1G2 PRKCD AFDN PHIP DYNC1H1 | 2.90e-07 | 1353 | 160 | 22 | 29467282 |
| Pubmed | BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity. | 3.81e-07 | 4 | 160 | 3 | 15644318 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HSP90B1 NUP85 RPN1 MATR3 KIF16B YTHDC2 CMAS STT3B PIKFYVE CYB5B TDRD3 FAF2 UTP4 RRP12 TMEM70 MRPS21 BYSL PRKCD ALAS1 TOP3B CLUH PHIP CYB5R1 | 4.04e-07 | 1496 | 160 | 23 | 32877691 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSP90B1 MYH11 POLR1A RPN1 MATR3 SPTBN2 CMAS STT3B KDM4D UTP4 CHD5 RRP12 UHRF1 TOP1MT MCTP2 USP6NL DYNC1H1 HDAC1 | 4.33e-07 | 949 | 160 | 18 | 36574265 |
| Pubmed | MYO1G HSP90B1 MAN2A1 NUP85 RPN1 MYO9B WWP2 MATR3 TUBGCP2 CMAS STT3B CYB5B CLCN7 CHD5 XRN1 BYSL ADAM17 MCTP2 DYNC1H1 CYB5R1 | 4.75e-07 | 1168 | 160 | 20 | 19946888 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | POLR1A RPN1 MYO9B CDK12 MATR3 YTHDC2 CMAS MSH6 TDRD3 RRP12 XRN1 ASPM BYSL UHRF1 TOP3B HDAC1 | 4.98e-07 | 759 | 160 | 16 | 35915203 |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 6.41e-07 | 211 | 160 | 9 | 17314511 | |
| Pubmed | 9.55e-07 | 163 | 160 | 8 | 16512683 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 9030885 | ||
| Pubmed | NUP85 COG7 MATR3 HAT1 TUBGCP2 DMAP1 MSH6 UTP4 AFDN CLUH DYNC1H1 HDAC1 HDAC2 | 2.17e-06 | 560 | 160 | 13 | 35241646 | |
| Pubmed | POLR1A SPTBN2 YTHDC2 MSH6 UTP4 RRP12 XRN1 BYSL AFDN ATM CLUH PHIP DYNC1H1 HDAC2 | 2.19e-06 | 653 | 160 | 14 | 22586326 | |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | POLR1A ERP44 RPN1 DNAJC16 STT3B MSH6 FAF2 CLCN7 PRKCD DYNC1H1 HDAC2 | 2.25e-06 | 392 | 160 | 11 | 33144569 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HSP90B1 KALRN MATR3 YTHDC2 TUBGCP2 TUBGCP5 PTK2 TDRD3 ENO3 TOP3B KCNT1 PHIP | 2.28e-06 | 475 | 160 | 12 | 31040226 |
| Pubmed | 2.99e-06 | 86 | 160 | 6 | 26885983 | ||
| Pubmed | RGPD2 HSP90B1 MYH11 NUP85 ZNF789 NLRP7 RPN1 MATR3 SPTBN2 FNBP1L STT3B CYB5B CHD5 XRN1 ASPM ATM TOP1MT CFAP69 TOP3B HDAC1 HDAC2 | 3.17e-06 | 1442 | 160 | 21 | 35575683 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 21931736 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 12628935 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SEMA3F HSP90B1 MAN2A1 ERP44 RPN1 DNAJC16 MATR3 KIF16B PPIL4 POMGNT1 HAT1 H6PD STT3B TINAGL1 CYB5B FAF2 TMEM70 ALAS1 ADAM17 USP6NL HDAC1 | 3.49e-06 | 1451 | 160 | 21 | 30550785 |
| Pubmed | 4.44e-06 | 92 | 160 | 6 | 37343697 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 37548402 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF131 HAT1 CMAS DMAP1 FSIP2 MSH6 UTP4 CHD5 MASTL UHRF1 PHIP HDAC1 HDAC2 | 5.28e-06 | 608 | 160 | 13 | 36089195 |
| Pubmed | CDK12 PIEZO1 MATR3 KIF16B CEMIP2 DMAP1 SEPTIN8 ACSBG1 PLCH2 CHD5 KCNT1 USP6NL | 6.81e-06 | 529 | 160 | 12 | 14621295 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | POLR1A PPIL4 YTHDC2 HAUS3 NIBAN2 FNBP1L PTK2 STT3B SEPTIN8 TDRD3 UTP4 XRN1 TOP3B CLUH | 7.13e-06 | 724 | 160 | 14 | 36232890 |
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 16537907 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 8.74e-06 | 157 | 160 | 7 | 30686591 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | TBC1D3H KALRN RPN1 MYO9B CDK12 PIEZO1 POMGNT1 DBI FLVCR2 PRCP MICAL3 PHIP | 1.04e-05 | 552 | 160 | 12 | 10737800 |
| Pubmed | SEMA4D SPTBN2 CEMIP2 STT3B CYB5B FAF2 CLCN7 AFDN USP6NL EPHA3 CYB5R1 | 1.17e-05 | 467 | 160 | 11 | 30194290 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DNAJC16 SPTBN2 KIF16B ARFGEF1 NIBAN2 CEMIP2 STT3B RAB33A CLCN7 MICAL3 USP6NL EPHA3 | 1.41e-05 | 569 | 160 | 12 | 30639242 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | 1.53e-05 | 11 | 160 | 3 | 16863688 | |
| Pubmed | MAN2A1 POLR1A NT5E CDK12 DNAJC16 PIEZO1 YTHDC2 CMAS STT3B DMAP1 MSH6 TDRD3 GTF2H1 UTP4 RRP12 XRN1 BYSL AFDN USP6NL HDAC1 | 1.94e-05 | 1497 | 160 | 20 | 31527615 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 1.97e-05 | 71 | 160 | 5 | 28319113 | |
| Pubmed | SEMA4D POLR1A RPN1 SPTBN2 SYT2 MSH6 DNAH12 RRP12 MRPS21 BYSL HDAC2 | 2.05e-05 | 496 | 160 | 11 | 31343991 | |
| Pubmed | DNAJC16 MAP3K4 FAF2 RRP12 MARK4 DAAM2 MICAL3 CLEC16A DYNC1H1 PLCE1 | 2.07e-05 | 407 | 160 | 10 | 12693553 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | POLR1A SPTBN2 YTHDC2 AK9 MAP3K4 DNAI1 DNAH12 RRP12 MICAL3 ATM TOP3B | 2.09e-05 | 497 | 160 | 11 | 36774506 |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21103356 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33090723 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26300108 | ||
| Pubmed | DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA). | 2.10e-05 | 2 | 160 | 2 | 3800865 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26195816 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27881734 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19923902 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26937641 | ||
| Pubmed | The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. | 2.10e-05 | 2 | 160 | 2 | 21502810 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37204028 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33090377 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15170927 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12557751 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36817472 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19729864 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16636671 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23967285 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24521869 | ||
| Pubmed | Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein. | 2.10e-05 | 2 | 160 | 2 | 18547142 | |
| Pubmed | Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. | 2.10e-05 | 2 | 160 | 2 | 14504267 | |
| Pubmed | Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity. | 2.10e-05 | 2 | 160 | 2 | 32934238 | |
| Pubmed | Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. | 2.10e-05 | 2 | 160 | 2 | 20802485 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 1971508 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9823308 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 7561109 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11919195 | ||
| Pubmed | Genetic dissection of histone deacetylase requirement in tumor cells. | 2.10e-05 | 2 | 160 | 2 | 19416910 | |
| Pubmed | Soluble Sema4D cleaved from osteoclast precursors by TACE suppresses osteoblastogenesis. | 2.10e-05 | 2 | 160 | 2 | 37170687 | |
| Pubmed | Human serum amyloid A. Three hepatic mRNAs and the corresponding proteins in one person. | 2.10e-05 | 2 | 160 | 2 | 3183061 | |
| Pubmed | HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells. | 2.10e-05 | 2 | 160 | 2 | 31071955 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 3857624 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25942572 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24449838 | ||
| Pubmed | Synaptotagmins 1 and 2 as mediators of rapid exocytosis at nerve terminals: the dyad hypothesis. | 2.10e-05 | 2 | 160 | 2 | 23648184 | |
| Pubmed | Dynamic distribution of HDAC1 and HDAC2 during mitosis: association with F-actin. | 2.10e-05 | 2 | 160 | 2 | 23280436 | |
| Pubmed | Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL. | 2.10e-05 | 2 | 160 | 2 | 25688158 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23516383 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10904264 | ||
| Pubmed | Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly. | 2.10e-05 | 2 | 160 | 2 | 30209338 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9605178 | ||
| Pubmed | Synaptotagmin I and II are present in distinct subsets of central synapses. | 2.10e-05 | 2 | 160 | 2 | 17492637 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31692265 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15297431 | ||
| Pubmed | Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity. | 2.10e-05 | 2 | 160 | 2 | 32572240 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30454891 | ||
| Pubmed | Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. | 2.10e-05 | 2 | 160 | 2 | 9823935 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19561124 | ||
| Pubmed | AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform. | 2.10e-05 | 2 | 160 | 2 | 24228751 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16152805 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 35608750 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26352599 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12077270 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14871291 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31162334 | ||
| Pubmed | RNA topoisomerase is prevalent in all domains of life and associates with polyribosomes in animals. | 2.10e-05 | 2 | 160 | 2 | 27257063 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9518179 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22037263 | ||
| Pubmed | Podocyte histone deacetylase activity regulates murine and human glomerular diseases. | 2.10e-05 | 2 | 160 | 2 | 30776024 | |
| Interaction | PTCH1 interactions | MAN2A1 RPN1 WWP2 PPIL4 CMAS CEMIP2 PIKFYVE GRK3 ADAM17 ATM TOP3B DYNC1H1 | 1.60e-06 | 273 | 157 | 12 | int:PTCH1 |
| Interaction | ACTR1A interactions | HSP90B1 MATR3 SPTBN2 BCL2 NEK4 MSH6 CLEC16A TOP3B DYNC1H1 HDAC1 HDAC2 | 1.04e-05 | 274 | 157 | 11 | int:ACTR1A |
| Interaction | SYNCRIP interactions | RPN1 WWP2 MATR3 YTHDC2 SYT2 BIN3 ZBTB14 MAP3K4 STT3B NEK4 TDRD3 SBF2 XRN1 BYSL SYT1 TOP3B DYNC1H1 HDAC2 | 1.36e-05 | 721 | 157 | 18 | int:SYNCRIP |
| Interaction | ZFPM1 interactions | 2.32e-05 | 22 | 157 | 4 | int:ZFPM1 | |
| Interaction | TOP3B interactions | SEMA3F HSP90B1 NUP85 KALRN MYO9B CDK12 PIEZO1 SPTBN2 POMGNT1 CDC14B TINAGL1 PIKFYVE ESRP2 TDRD3 CLCN7 TULP4 CHD5 SBF2 RRP12 MARK4 XRN1 BYSL AP1G2 MICAL3 RBM47 TOP3B DYNC1H1 | 2.51e-05 | 1470 | 157 | 27 | int:TOP3B |
| Interaction | NRAS interactions | SEMA4D SPTBN2 BCL2 NIBAN2 CEMIP2 STT3B SEPTIN8 CYB5B RAB33A FAF2 CLCN7 PRKCD AFDN USP6NL EPHA3 CYB5R1 PLCE1 | 3.33e-05 | 699 | 157 | 17 | int:NRAS |
| Interaction | SMG7 interactions | RPN1 SYT2 TDRD3 CHD5 RRP12 XRN1 BYSL RBM47 CLEC16A TOP3B PHIP | 4.23e-05 | 319 | 157 | 11 | int:SMG7 |
| Interaction | KIF23 interactions | HSP90B1 MYH11 RPN1 MYO9B MATR3 PABPC4L YTHDC2 AK9 MAP3K4 MSH6 FAF2 UTP4 RRP12 MRPS21 ASPM UHRF1 MICAL3 TOP1MT TOP3B PHIP DYNC1H1 | 5.22e-05 | 1031 | 157 | 21 | int:KIF23 |
| Interaction | CIT interactions | HSP90B1 MYH11 POLR1A ERP44 KALRN RPN1 MYO9B MATR3 SPTBN2 PPIL4 YTHDC2 MAP3K4 MSH6 DNAH12 FAF2 UTP4 RRP12 BYSL UHRF1 TOP1MT RBM47 TOP3B PHIP DYNC1H1 HDAC1 HDAC2 | 5.43e-05 | 1450 | 157 | 26 | int:CIT |
| Cytoband | 11p15.1-p14 | 3.61e-05 | 3 | 160 | 2 | 11p15.1-p14 | |
| Cytoband | 16q22.1 | 4.40e-05 | 110 | 160 | 5 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 4.75e-04 | 183 | 160 | 5 | chr16q22 | |
| GeneFamily | Myosins, class IX | 3.60e-05 | 2 | 109 | 2 | 1103 | |
| GeneFamily | PHD finger proteins|NuRD complex | 4.51e-05 | 12 | 109 | 3 | 1305 | |
| GeneFamily | Dyneins, axonemal | 1.36e-04 | 17 | 109 | 3 | 536 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 2.14e-04 | 4 | 109 | 2 | 989 | |
| GeneFamily | Topoisomerases | 5.32e-04 | 6 | 109 | 2 | 1050 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.26e-03 | 9 | 109 | 2 | 1306 | |
| GeneFamily | Tudor domain containing | 1.43e-03 | 37 | 109 | 3 | 780 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 2.28e-03 | 12 | 109 | 2 | 1243 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 2.28e-03 | 12 | 109 | 2 | 445 | |
| GeneFamily | Synaptotagmins | 4.62e-03 | 17 | 109 | 2 | 765 | |
| Coexpression | LEE_BMP2_TARGETS_DN | ZNF131 MMS22L POLR1A NUP85 NT5E HAT1 YTHDC2 HAUS3 COQ10B MSH6 UTP4 RRP12 BYSL UHRF1 DAAM2 MCTP2 CLUH HDAC1 HDAC2 | 2.37e-06 | 904 | 158 | 19 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | ZNF131 MMS22L POLR1A NUP85 NT5E HAT1 YTHDC2 HAUS3 COQ10B MSH6 UTP4 RRP12 BYSL UHRF1 DAAM2 MCTP2 CLUH HDAC2 | 1.21e-05 | 922 | 158 | 18 | MM1068 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAN2A1 MYO9B ARFGEF1 HAT1 FNBP1L RGS7 PTK2 MAP3K4 NEK4 PIKFYVE MSH6 TDRD3 MICAL3 ADAM17 CLEC16A PHIP PLCE1 | 1.73e-05 | 856 | 158 | 17 | M4500 |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 3.03e-05 | 200 | 158 | 8 | M8032 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 3.03e-05 | 200 | 158 | 8 | M8030 | |
| Coexpression | GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN | 3.03e-05 | 200 | 158 | 8 | M7237 | |
| Coexpression | GSE2585_CTEC_VS_MTEC_THYMUS_DN | 3.03e-05 | 200 | 158 | 8 | M6274 | |
| Coexpression | GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP | 3.78e-05 | 151 | 158 | 7 | M6498 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-09 | 179 | 160 | 10 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-08 | 180 | 160 | 9 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-08 | 180 | 160 | 9 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.02e-08 | 196 | 160 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.02e-08 | 196 | 160 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-07 | 189 | 160 | 8 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-07 | 194 | 160 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 169 | 160 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-06 | 171 | 160 | 7 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.07e-06 | 180 | 160 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.21e-06 | 192 | 160 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 6.21e-06 | 192 | 160 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.43e-06 | 193 | 160 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.43e-06 | 193 | 160 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.43e-06 | 193 | 160 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 195 | 160 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.59e-06 | 198 | 160 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-06 | 198 | 160 | 7 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.60e-05 | 148 | 160 | 6 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-05 | 90 | 160 | 5 | f1415181bad5e2cf87eedd8563c0f1d20adc4cce | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 158 | 160 | 6 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 158 | 160 | 6 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 159 | 160 | 6 | 886cbaef39a3517514a3896b6b960d01a3af043d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.64e-05 | 97 | 160 | 5 | 332b4daf5106872dd891d9f9b5a891192d5d9aa8 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 162 | 160 | 6 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 162 | 160 | 6 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 163 | 160 | 6 | 04152557aae230e9587fcc16cbabf1247cc5b419 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 163 | 160 | 6 | 0644eb8a66d4e944063125c423de66d2393388b1 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-05 | 166 | 160 | 6 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 168 | 160 | 6 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-05 | 168 | 160 | 6 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-05 | 168 | 160 | 6 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-05 | 168 | 160 | 6 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-05 | 168 | 160 | 6 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.38e-05 | 169 | 160 | 6 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 169 | 160 | 6 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 169 | 160 | 6 | 411556e93adcbb7e4d79b02f3dc72963ec8a0759 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-05 | 169 | 160 | 6 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 169 | 160 | 6 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 169 | 160 | 6 | 39b1acfd099abb9de18c29c05c7a67709ea76775 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-05 | 169 | 160 | 6 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 169 | 160 | 6 | 2a35846b0e0be0a19a5a04a86cbd72ce65257c8a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-05 | 169 | 160 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 170 | 160 | 6 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 170 | 160 | 6 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 171 | 160 | 6 | e7dbee63cc39230aa12e7868ec78a129160c0d22 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 171 | 160 | 6 | b0d616699e2110ffd6cf1868ed1f1a29f824e1fc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 173 | 160 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.10e-05 | 175 | 160 | 6 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.51e-05 | 178 | 160 | 6 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.11e-05 | 182 | 160 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.26e-05 | 183 | 160 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 5.43e-05 | 184 | 160 | 6 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 184 | 160 | 6 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 185 | 160 | 6 | ff95a45b7cb782961bb8f008b6b507af2d4cb8b7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.59e-05 | 185 | 160 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 185 | 160 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 5.59e-05 | 185 | 160 | 6 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 5.93e-05 | 187 | 160 | 6 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 187 | 160 | 6 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 5.93e-05 | 187 | 160 | 6 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 5.93e-05 | 187 | 160 | 6 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 187 | 160 | 6 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.11e-05 | 188 | 160 | 6 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.29e-05 | 189 | 160 | 6 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 189 | 160 | 6 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.29e-05 | 189 | 160 | 6 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.29e-05 | 189 | 160 | 6 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 190 | 160 | 6 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-05 | 190 | 160 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 6.48e-05 | 190 | 160 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.48e-05 | 190 | 160 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-05 | 191 | 160 | 6 | 6a8b0987e75456a257954288206da0032605ff2a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.67e-05 | 191 | 160 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.67e-05 | 191 | 160 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.67e-05 | 191 | 160 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.87e-05 | 192 | 160 | 6 | 03acd4a26b986e34eee608747347791122f1aa52 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 6.87e-05 | 192 | 160 | 6 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.87e-05 | 192 | 160 | 6 | 31c6046589e2fbb0486fd044c5b128099d37872f | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 6.87e-05 | 192 | 160 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 6.87e-05 | 192 | 160 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.87e-05 | 192 | 160 | 6 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 193 | 160 | 6 | 33437fdb417d78463caee14a9f0e094da1733829 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 7.07e-05 | 193 | 160 | 6 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 160 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.27e-05 | 194 | 160 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 7.48e-05 | 195 | 160 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-05 | 195 | 160 | 6 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 7.48e-05 | 195 | 160 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 7.48e-05 | 195 | 160 | 6 | 8b307079cee67fc1df55277d0cab21ea4b97e552 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 7.48e-05 | 195 | 160 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.48e-05 | 195 | 160 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.48e-05 | 195 | 160 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.91e-05 | 197 | 160 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | CDK12 RBL2 SLC25A14 FNBP1L GRK3 CLCN7 RRP12 RBM47 MPPE1 ENOX2 | 1.06e-06 | 195 | 157 | 10 | 207_UP |
| Drug | AC1L1IZ2 | MGAM HSP90B1 MYH11 MYO9A MYO9B RBL2 PTK2 STT3B GRK3 AFDN DYNC1H1 EPHA3 | 1.40e-06 | 304 | 157 | 12 | CID000004795 |
| Drug | purealin | 2.94e-06 | 58 | 157 | 6 | CID006419303 | |
| Drug | 10-hydroxycamptothecin | 7.92e-06 | 40 | 157 | 5 | CID000097226 | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.40e-06 | 194 | 157 | 9 | 3316_DN | |
| Drug | UCN-01 | 1.19e-05 | 154 | 157 | 8 | CID000072271 | |
| Disease | serum amyloid A protein measurement | 2.81e-06 | 6 | 155 | 3 | EFO_0004728 | |
| Disease | forced expiratory volume | CDK12 WWP2 PIEZO1 SPTBN2 PABPC4L AK9 CYB5B DNAH12 TULP4 MRPS21 UHRF1 MICAL3 CLEC16A PHIP | 7.63e-05 | 789 | 155 | 14 | EFO_0004314 |
| Disease | waist-hip ratio | MMS22L MYH11 NUP85 MYO9B RBL2 WWP2 ARFGEF1 YTHDC2 BCL2 H6PD CYB5B SBF2 XRN1 ADAM17 CLEC16A PHIP EPHA3 PLCE1 | 8.27e-05 | 1226 | 155 | 18 | EFO_0004343 |
| Disease | Antihypertensive use measurement | 8.40e-05 | 265 | 155 | 8 | EFO_0009927 | |
| Disease | serum amyloid A-1 protein measurement | 1.09e-04 | 18 | 155 | 3 | EFO_0008282 | |
| Disease | total blood protein measurement | 1.39e-04 | 449 | 155 | 10 | EFO_0004536 | |
| Disease | Adenocarcinoma of large intestine | 1.56e-04 | 96 | 155 | 5 | C1319315 | |
| Disease | congenital myasthenic syndrome 7 (implicated_via_orthology) | 1.63e-04 | 4 | 155 | 2 | DOID:0110659 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (is_implicated_in) | 1.63e-04 | 4 | 155 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | congenital myasthenic syndrome (is_implicated_in) | 1.63e-04 | 4 | 155 | 2 | DOID:3635 (is_implicated_in) | |
| Disease | Chronic Lymphocytic Leukemia | 2.03e-04 | 55 | 155 | 4 | C0023434 | |
| Disease | neuromuscular junction disease (implicated_via_orthology) | 2.71e-04 | 5 | 155 | 2 | DOID:439 (implicated_via_orthology) | |
| Disease | vital capacity | CACNA1S SEMA4D MMS22L CDK12 WWP2 PIEZO1 SPTBN2 AK9 HVCN1 CDC14B CYB5B TULP4 UHRF1 SYT1 MICAL3 EPHA3 PLCE1 | 2.83e-04 | 1236 | 155 | 17 | EFO_0004312 |
| Disease | breast carcinoma (is_marker_for) | 4.10e-04 | 66 | 155 | 4 | DOID:3459 (is_marker_for) | |
| Disease | smoking status measurement | SEMA3F ZNF131 MMS22L MAN2A1 NRAP POLR1A ZNF789 WWP2 PTK2 CYB5B LRGUK TULP4 TTC29 XRN1 BYSL UHRF1 | 4.18e-04 | 1160 | 155 | 16 | EFO_0006527 |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.23e-04 | 28 | 155 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | X-12063 measurement | 4.65e-04 | 186 | 155 | 6 | EFO_0021283 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 5.20e-04 | 30 | 155 | 3 | C1868672 | |
| Disease | focal segmental glomerulosclerosis (implicated_via_orthology) | 5.66e-04 | 7 | 155 | 2 | DOID:1312 (implicated_via_orthology) | |
| Disease | argininate measurement | 7.52e-04 | 8 | 155 | 2 | EFO_0800055 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 7.55e-04 | 34 | 155 | 3 | DOID:9952 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 9.43e-04 | 142 | 155 | 5 | DOID:10534 (is_marker_for) | |
| Disease | alopecia areata (is_marker_for) | 1.20e-03 | 10 | 155 | 2 | DOID:986 (is_marker_for) | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 1.40e-03 | 42 | 155 | 3 | DOID:8991 (is_marker_for) | |
| Disease | chronic musculoskeletal pain | 1.75e-03 | 12 | 155 | 2 | EFO_0022195 | |
| Disease | Intestinal Neoplasms | 1.75e-03 | 12 | 155 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 1.75e-03 | 12 | 155 | 2 | C0346627 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.39e-03 | 14 | 155 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | POLR1A KALRN RPN1 MYO9A CDK12 PIEZO1 BCL2 FNBP1L ACSBG1 SBF2 MARK4 AFDN | 2.44e-03 | 880 | 155 | 12 | EFO_0007978 |
| Disease | Replication Error Phenotype | 2.75e-03 | 15 | 155 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 2.75e-03 | 15 | 155 | 2 | C0920269 | |
| Disease | urate measurement | MYO9A DNAJC16 FNBP1L STT3B CYB5B SBF2 UHRF1 SYT1 PRKCD GJA10 RBM47 TDRD12 | 2.80e-03 | 895 | 155 | 12 | EFO_0004531 |
| Disease | mean platelet volume | SEMA3F MYH11 KALRN RPN1 MYO9B CDK12 KIF16B BCL2 RFX2 MARK4 MRPS21 PHIP PLCE1 | 2.91e-03 | 1020 | 155 | 13 | EFO_0004584 |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.13e-03 | 16 | 155 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 3.54e-03 | 17 | 155 | 2 | C0751883 | |
| Disease | Endometrial Neoplasms | 3.55e-03 | 58 | 155 | 3 | C0014170 | |
| Disease | immature platelet measurement | 3.64e-03 | 119 | 155 | 4 | EFO_0803541 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.91e-03 | 60 | 155 | 3 | C4722327 | |
| Disease | Squamous cell carcinoma | 4.22e-03 | 124 | 155 | 4 | C0007137 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 4.42e-03 | 19 | 155 | 2 | C0751884 | |
| Disease | tea consumption measurement | 4.85e-03 | 129 | 155 | 4 | EFO_0010091 | |
| Disease | end stage renal disease (implicated_via_orthology) | 4.90e-03 | 20 | 155 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of prostate | 4.90e-03 | 20 | 155 | 2 | C0007112 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLEFHGVMRFYFQDK | 36 | P55196 | |
| AVHRAYETSKMYRDF | 126 | Q8N3I7 | |
| HGVFSEKEMRFYATE | 286 | P35626 | |
| KGAFYLVFEYMDHDL | 806 | Q9NYV4 | |
| EFYDATAHFAKGLEM | 316 | P83436 | |
| EKEFRAYVSLFMRHL | 1461 | Q8TDI0 | |
| RMYDAKRFTDAGFDH | 266 | O60729 | |
| MYDVVSGVEDYKHFV | 91 | Q9H8M1 | |
| AFVKFTHDQIMRRYG | 181 | Q53H80 | |
| EVMYAYVDQHDFSGK | 761 | Q9Y6D6 | |
| VYMGHALYRLRAFEK | 91 | Q969M2 | |
| LLHIYGYFDEEMAVK | 121 | Q96GX5 | |
| EYDTLFRKYDHMRAA | 566 | O75843 | |
| AFDFHKEIDYMFLVG | 501 | Q9UI46 | |
| RMYDAKRFTDAGFDH | 236 | A4D256 | |
| QSFYRMHRAKVDYET | 2696 | Q8IZT6 | |
| RSHLEKYLRDFFSVM | 1261 | Q96L93 | |
| ERFRKSMVEHYYRNV | 96 | Q14088 | |
| MKNRGFAFVEYESHR | 191 | A0AV96 | |
| YHMVYEQAKARFEEV | 276 | Q96TA1 | |
| IYREMGFGHYEEEES | 411 | Q8WUA2 | |
| AEEAQYGRFLELHMY | 661 | Q96PH1 | |
| EIASKHFRFAEMLYY | 486 | Q08999 | |
| HFRFAEMLYYKVLES | 491 | Q08999 | |
| DLEDFEKMFSAYQRH | 636 | Q86T65 | |
| RLRSMYGAHKYQAEF | 366 | P59901 | |
| VYVMERLSAEGKFFH | 771 | Q7RTP6 | |
| FHYFSDRMGILDIEV | 406 | Q6DN12 | |
| HNYHKFDSEYERMGR | 241 | P43243 | |
| MESHLRAAEILYYFA | 521 | Q16706 | |
| LYKAAGEDARHEYTM | 1236 | Q86VF7 | |
| DRVMTVSFHKYGEYF | 191 | Q13547 | |
| LHFEVMSEREKSYFS | 616 | P13196 | |
| MARLADYFIVVGYDH | 1 | Q86WG5 | |
| MYHIQDKGRFELYRA | 436 | Q05655 | |
| FYKFDRHGVPDEMRK | 361 | Q6ZRQ5 | |
| MSKFLRHFTVVGDDY | 21 | Q96D96 | |
| HADIDYMDERRDFTY | 411 | O43451 | |
| HIRFAEEYMVDKALY | 166 | Q16206 | |
| EVYHIRMGDSKFFRE | 541 | Q5JUK3 | |
| FIEMGKGENLRVFHY | 3291 | Q5CZC0 | |
| GRFDSEKMAYTIHEI | 361 | P51798 | |
| DPAHYRERVKAMFYH | 31 | Q9BV94 | |
| GFHYEMNTYKVERFE | 161 | Q53F39 | |
| TFLGKYREFHRMYGE | 536 | Q9BW27 | |
| YREFHRMYGEKRFAD | 541 | Q9BW27 | |
| EVRLREHMGEKYTTY | 811 | P51957 | |
| VDKHYRDFSLRMGKY | 1216 | O60229 | |
| DKHFMERDYTGYVLA | 686 | Q9Y2G8 | |
| FHYDYGMRAVKAVLV | 1421 | Q6ZR08 | |
| MNGREYHYVSKETFE | 471 | Q96JB8 | |
| EELKAMLVFAEHRYY | 111 | P42785 | |
| FDKYIAYMESQGAHR | 31 | Q6B0I6 | |
| IKRYFLMDQGDFFVH | 516 | Q9BSJ2 | |
| ARMYLEQSDFHEKFA | 651 | Q96RT8 | |
| AYFLRHFGDEDQAMR | 366 | Q9NX02 | |
| HMEIEGVRSLKYSYF | 511 | Q96M69 | |
| YDGEEHGRFMEKLET | 41 | Q9Y2D4 | |
| KFYELYHMDALIGVS | 431 | P52701 | |
| LYVRRVFITDDFHDM | 411 | P14625 | |
| SVLVKYSGYLEHMDR | 56 | O75344 | |
| YAGEFHKMREVILDS | 1826 | Q9Y2I7 | |
| KVSETFGYRRLEDFM | 1196 | Q13315 | |
| IYKADMTCRGFREYH | 161 | O14929 | |
| RVYGELMRYAHDLKT | 96 | Q5T0N5 | |
| EHFRKFMKRQEEYYG | 1531 | Q13698 | |
| EGMHREVYALLYSDK | 51 | Q9NPF5 | |
| VGHSSDAREMLKQYY | 81 | O43169 | |
| DAREMLKQYYIGDIH | 86 | O43169 | |
| VVYYSEMHKIFGDLS | 206 | Q9NQY0 | |
| HQMEREFYVYFLKDE | 566 | Q68CZ6 | |
| HRMFYEALDKYGDLI | 106 | Q96GR2 | |
| SDEEMLFIYGHYKQA | 21 | P07108 | |
| KDAYVGRMDNYLIRH | 961 | Q9UHN6 | |
| NLYYMESDDDHGVKF | 121 | P29320 | |
| EDRDELAYHISIMFY | 241 | Q9UPI3 | |
| FRHMYVFGDFKDVLI | 326 | Q9BS26 | |
| GEVFDYLVSHGRMKE | 141 | Q96L34 | |
| LGTRKLMHVAYEEFE | 396 | Q14204 | |
| YRKLAGLVEEMHAAY | 181 | P04180 | |
| SSFKEAMRIGAEVYH | 176 | P13929 | |
| TGYDMARNAYHFKRV | 146 | P60008 | |
| TDRVMTVSFHKYGEY | 191 | Q92769 | |
| EEEMYRVDHYLGKQA | 196 | O95479 | |
| HPRFRYKEHEDGYMR | 376 | Q9BQA5 | |
| YKEHEDGYMRLQLVR | 381 | Q9BQA5 | |
| EVFKNLFMRGFSHYD | 291 | A5D8W1 | |
| FSGEMHFYELVEDTK | 101 | O00237 | |
| DVAEYKRLNFHLYMA | 261 | Q13895 | |
| GLRHLMFYYQDVEEA | 76 | Q8TE73 | |
| EMYIFGKFETFHRRL | 466 | Q8TE73 | |
| ETFMNKFIYEIARRH | 156 | P02771 | |
| KYRMASLYVGDLHAD | 6 | P0CB38 | |
| FLKAFYVVHRYEDLM | 631 | O14829 | |
| NFGFEYHKEVVRLMS | 1041 | Q9Y6R4 | |
| VMAVYDFDRFSKHDI | 226 | P21579 | |
| TLVMAIYDFDRFSKH | 221 | Q8N9I0 | |
| SLEFAAEFRGHYYKM | 1661 | Q5TCS8 | |
| MGEFKVHRVRFFNYV | 1 | Q969X6 | |
| RYTFEDAQEHIYKLM | 416 | P49802 | |
| LMEVHEDFFLYKGGI | 366 | Q9GZM7 | |
| HKYEEFMLRRYLASD | 186 | Q6ZMZ0 | |
| EHYMELVYRGLTDKV | 651 | O95602 | |
| KFYRAEVEALHSSGM | 571 | Q9H7E2 | |
| DMREANYIGSDKYFH | 41 | P0DJI9 | |
| HDRMYVGSKDYVLSL | 66 | Q13275 | |
| SFYFAKRHLIEMGYL | 216 | Q8NFW8 | |
| GSMEEKREVFSYLVH | 616 | Q9P212 | |
| DEYMFYLVEHRVAEA | 646 | P48378 | |
| SHMAELYRYDKDVGQ | 1351 | P0DJD1 | |
| YFGRIVDKHMDLYAT | 896 | Q587J7 | |
| EGHTYVAFIRMEKDD | 571 | Q8WZA1 | |
| ETLKGDHVYFFRMVI | 421 | Q9NTG1 | |
| GAMERVLKVFHYFES | 31 | Q05397 | |
| IVSFMHSFEEKYGRA | 136 | Q96CS3 | |
| GDQYALKMRFVDHVF | 346 | P04843 | |
| AYFLRHFGDEDQAMR | 331 | Q8WX94 | |
| YDVMFVSTDRGALHK | 436 | Q92854 | |
| HMGVRYIEVYKATGE | 321 | Q9H6T0 | |
| AYSKGFVTADMIREH | 251 | Q9UHQ9 | |
| MFRAVEEGLTYKFHA | 471 | Q5JTH9 | |
| DMREANYIGSDKYFH | 41 | P0DJI8 | |
| YKGAEVAHFMNALRY | 96 | P21589 | |
| RTGYDNREIVMKYIH | 6 | P10415 | |
| KLLVVADHRFYRYMG | 226 | P78536 | |
| RHFYKGEDIFLDMFE | 601 | Q2KHT3 | |
| YRARYLMLLVFGEDH | 1086 | O75153 | |
| RDERTFHIFYYMIAG | 276 | P35749 | |
| HMFFRDRYGTKQREL | 156 | A6NDS4 | |
| HMFFRDRYGTKQREL | 156 | P0C7X1 | |
| RKFHYFVDSIAGMDE | 591 | O95985 | |
| DARFKEIKYRGMFHA | 76 | O95258 | |
| SAMVKFYNVRGEHIF | 321 | Q9NRJ4 | |
| EGKDRFTISHMYADI | 36 | P32780 | |
| SDMKFEYLLYGHHRE | 261 | O43829 | |
| TFRDHIMFRDRYGVK | 151 | Q92738 | |
| EMKYTSEGVRYFVDH | 451 | O00308 | |
| YFRQGHEAYVEMARK | 966 | Q8WWQ0 | |
| YEHVTMLRDKFREFS | 1726 | O15020 | |
| LGYLEAEMKTYSHRT | 16 | P35247 | |
| EKYGNIRYEDIHSMR | 751 | Q0IIM8 | |
| TMDGLIEDIKHRRYY | 31 | P82921 | |
| GYRHVYLEGMEEASI | 861 | O75038 | |
| FSNVFEHYLGDDMKR | 476 | Q8TCJ2 | |
| GTEFMARLHEHLKYF | 136 | Q8IZH2 | |
| EVATFYGRMLDHEYT | 91 | Q969P6 | |
| YGRMLDHEYTTKEVF | 96 | Q969P6 | |
| FHYSVKMGDRSVYNE | 126 | Q7Z5A4 | |
| HYELYRRCKLEEMGF | 296 | Q92599 | |
| DYFKVGRHVDAMNEY | 316 | Q96N46 | |
| FEAMYRKETTSFHLE | 81 | A0A075B6T8 | |
| FYRGKQMEDGHTLFD | 46 | Q96T88 | |
| DKRFADSTHRYQVFM | 646 | Q9H6S0 | |
| IEAIRAEYHKMVAFF | 176 | A0A3B3IT33 | |
| GYHKSFTELFALMER | 76 | Q8NA56 | |
| TAFMRYYHVFREGEL | 406 | Q9P272 | |
| NKTYVEGDMFLHSRF | 371 | Q9H0C3 | |
| GVSKMAFRHLIEFTY | 76 | P52739 | |
| HTKYRAATDVYALMF | 1951 | Q92508 | |
| AIMQVREDFFHYKTG | 376 | Q9UJW2 | |
| DYIHLMGYDKEEFIL | 231 | Q9BUB7 | |
| HMFFRDRYGTKQREL | 156 | Q6DHY5 | |
| RGKELLSFEDVAMYF | 6 | Q5FWF6 | |
| DKTMEFGRDFRIKHY | 506 | B0I1T2 | |
| IEMHGLYTEGIYRKS | 2086 | B2RTY4 | |
| EHVEMHGLYTEGLYR | 1721 | Q13459 |